UBS analyst Joshua Chan raised the firm’s price target on Xometry (XMTR) to $22 from $20 and keeps a Neutral rating on the shares following the Q3 report.
UBS analyst Joshua Chan raised the firm’s price target on Xometry (XMTR) to $22 from $20 and keeps a Neutral rating on the shares following the Q3 report.